CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 1attorney advertising
Dubai, 7 May 2014almaty I ashgabat I astana I buenos aires I dubai I frankfurt I houston
istanbul I london I mexico city I milan I muscat I new york I paris I washington, d.c. www.curtis.com
The Role of Ethics in the Compliance Decision-Making Process
Jean-Claude Najar
8th International Pharmaceutical Compliance Congress & Best Practices Forum
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 2
Introductory Observations
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 3copyright jean-claude najar
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 4
Ethics Matters !
• Not just a risk management issue
• The healthcare industry…based on ethics:– Between the company and the patient– Patient is not an ordinary ‘client’– Making profits contingent on providing benefit
• This end-purpose can only be achieved if the company inspires “trust and confidence on the part of the medical community, patients, government officials, regulators, journalists, investors and other stakeholders. Even more, [the company] needs to inspire trust and confidence among [its own employees]”. (Jean-Paul Kress, President of Sanofi Pasteur)
• Ethical behaviour establishing trust
Globalized… interconnected environment… information on (un)ethical behavior now just a click away
copyright jean-claude najar
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 5
Information… Just One Click Away
copyright jean-claude najar
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 6
Unethical Behaviour: A Major Reputational Risk
• Reputation is key:
Reputation is an intangible asset
Reputation enables the generation of income
Reputation secures the activity as a going concern
Reputational damages… loss of future profit
Loss of reputation = loss of business
• A fragile asset… difficult to build, easily destroyed
copyright jean-claude najar
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 7
Ethical Behaviour
• To conduct business effectively and to promote confidence in the integrity of the company, its managers and employees… maintain the highest standards of loyalty and ethical principles
• Avoiding situations where personal activities or relationships could create, or appear to create, a conflict of interest… or make it difficult to carry out job responsibilities … or act in the best interest of the company
copyright jean-claude najar
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 8
What is Culture in a Company?
• Culture is the culmination of the shared attitudes, values, goals and practices that characterize an organization and set the environment which influences how employees behave.
• Compliance programs must be designed to help leaders – everyone – build a culture of compliance that positively impacts employee behavior.
copyright jean-claude najar
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 9
“Culture guides discretionary behavior and it picks up where the employee handbook leaves off. Culture tells us how to respond to an unprecedented service request. It tells us whether to risk telling our bosses about our new ideas, and whether to surface or hide problems. Employees make hundreds of decisions on their own every day, and culture is our guide. Culture tells us what to do when the CEO isn’t in the room, which is of course most of the time.”
Frances Frei and Anne Morriss in the Harvard Business Review (HBR), May 10, 2012
Company Culture Matters
“Maintaining an effective culture is so important that it, in fact, trumps even strategy.”
Howard Stevenson (Harvard Business School Professor of Business Administration, Emeritus)
copyright jean-claude najar
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 10
It’s All About Culture
copyright jean-claude najar
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 11
Outline
I. Defining Compliance and Ethics
II. The Business Rationale for Incorporating Ethics into the Compliance Decision-Making
III. Corporate Compliance Decision-Making and How Ethics Can be Incorporated
IV. Best Practices
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 12
IDefining
Compliance & Ethics
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 13
Definitions: Compliance & EthicsCompliance
•Much broader than only anti- corruption… risk management & abatement embedded in a risk management system & processes… Rules and values !
•The entirety of a program which analyzes the legal, business & ethical risks a company faces, finds methods to reduce (‘abate’) them, builds processes to anchor these methods into the way the company operates, and makes sure that these processes are sustainable
Ethics• “Moral principles that govern a person’s behavior or the conducting of an activity.” (Oxford Dictionary)
•“…the system or code of morals of a particular […]group, profession etc. (Webster’s)
•What is right vs what is wrong
•Ethics is a subjective notion
• A more objective conception of Ethics is embedded and expressed in laws and regulations
copyright jean-claude najar
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 14
Industry Standards
International Standards & Instruments
National Laws & Regulations
Sources of Ethics Objective Ethics
Individual Decision
Company Policy & Compliance Program
Subjective Ethicscopyright jean-claude najar
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 15
Ethics in the Normative Environment• Three groups of laws and regulations :
– Compulsory: imposed on the company by local laws and regulations. Compulsory regulation is the expression of the public’s/society’s ethics as a whole. It responds to an objective approach to ethics.
– Compromissory: agreed upon by the company in order to fit an international or an industry standard. Compromissory regulation is the expression of a common industry ethos.
– Self-regulation: decided by the company. The company regulates itself according to its own notion of ethics and its values… ‘limited’ by the requirements imposed or agreed upon by compulsory and compromissory regulation. It responds to a subjective approach to ethics.
Compliance decision-making process subject to the limits and the standards in these three groups of regulations: imposed, agreed or decided upon…
copyright jean-claude najar
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 16
Who Sets Ethical Standards?
Individuals!
Legislators and regulators
International bodies
Professional and standard-setting associations…
Stakeholders
Companies and employees
copyright jean-claude najar
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 17
IIThe Business Rationale for
Incorporating Ethics into the Compliance Decision-Making
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 18
Ethics in Risk Management – A Global Environment
• Complex regulated & globalized legal environment: Varying legal cultures (common law / civil law and multiplication of competent jurisdictions…of responsibilities…of faults (obligation of security, vigilance…)… of damagesConnection(s) with local criminal / penal laws… development of ‘soft law’Extra-territorial laws: the U.S. Foreign Corrupt Practices Act (1977) and the UK Bribery Act (2010)Each country with its own conception of ethics (public policy)Healthcare regulations not homogenousGlobal / local financial stability based on macro-economic requirements (EU competition law…) and micro-economic ones (SOX (US), Basel II & III (EU)…)
• Challenges for corporations:Complying with national, local, regional, transnational, international norms… Increased enforcement activities by –and cooperation between- regulatory authoritiesHaving internal controls & self-regulation policies efficiently converge: creating a common company-wide ethical standard complying with compulsory, compromissory and its own regulatory environment
In a globalized environment, taking ethics into consideration… a necessity in risk management
copyright jean-claude najar
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 19
Ethics in Pharma Risk Management
• Bribery & corruption
• Competition law
• Off-label marketing
• Generics
• Industry-specific risks
• An industry with many interdependencies
Not “putting profits ahead of patient health”copyright jean-claude najar
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 20
Ethics & Compliance
• Compliance with rules necessary, but not sufficient to ensure that no breach of the law occurs
• Strict respect of national laws & regulations and international instruments
• But ethical underpinning promotes sustainable growth and performance improvement…. Reliance on fundamental assets of the company : focus on excellence in terms of technology, production, competitiveness, and talent…
• « The two faces of the same coin » (Philippe Montigny, President & CEO, ETHIC Intelligence, 2014)
copyright jean-claude najar
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 21
Rules-based programs : ‘Is it legal?’vs.
Values-based programs :‘Is it ethical?’
“In a rules-based compliance culture the question is “Can I?”
In a values-based ethical culture the question is “Should I?”
In a rules-based culture the question is, “Is it legal?”
In a values-based culture the question is, “Is it ethical?” Michael Josephson, Founder, Josephson,Institute of Ethics, October 12, 2012
DNA of an Ethics & Compliance Program
copyright jean-claude najar
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 22
Ethical Behaviour: A Competitive Advantage• Healthcare industry based on ethics. ‘Trust and confidence’.• Strong ethics buys reputation: a customer / patient is more likely to buy a product on
which his/her health depends from a company he/she trusts than from one that consistently puts « profit before the patient’s health ».
• Good reputation: strengthens market positionreduces the cost of capital increases shareholder valueinsulates the brandSuggests a higher quality of product (higher prices)attracts top talent…sustains work environment. Unethical corporate behaviour creates pressure on the employees - may even alienate them from their loved ones.
“Our ethical conduct should be something that truly differentiates us from other companies.” (Andrew Witty, CEO of GSK)
copyright jean-claude najar
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 23
Unethical Behaviour… Not Viable in the Long RunDamaging to reputation
• Damages the reputation of an entire sector• A French study shows that patient trust in the drugs they
buy has fallen from 87% to 75% since 2013 • In France, scandals like the Mediator, the Isoméride, the
Furosémide, the PIP prosthetics, Distilbène or Diane 35 have increased distrust in the industryCostly… huge fines
• $1.5 billion Abbott settlement in Depakote case• $3 billion GSK settlement after investigations of its
Medicaid prices & False Claims Act accusations for the allegedly illegal marketing of ten drugs (including Avandia)
• $60.2 million Pfizer settlement in FCPA-related bribery allegations in China
• $29.4 million Eli Lilly & Co. settlement for alleged bribery of foreign officials in China
• $30 billion total in sanctions to the US DOJ paid so far by the Pharma industry
copyright jean-claude najar
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 24
IIIIncorporating Ethics into Compliance
Decision-Making
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 25
Building Blocks / Steps
copyright jean-claude najar
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 26
Building Blocks / Steps
• Tone at the top• Risk assessment (risk mapping) or
identification of issues• Raising & resolving concerns• Training• Communication• Evaluation
copyright jean-claude najar
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 27
Engagement By Leaders
‘Tone at the top’
•Leaders hire the people•They own the processes•They set the priorities•They create the environment•They set the expectations for the compliance culture…. •Their engagement is visible•Compliance is part of the their business agendas
‘Walk the talk’copyright jean-claude najar
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 28
Mission of a Compliance Department
• “…The mission of the Global Compliance organization at Sanofi is to shape an environment and build processes that instill ethical values … and to articulate clear standards of compliant behavior so that the Group and our external stakeholders view Sanofi as a global leader in upholding its ethical values.” (Sanofi CSR Factsheet May 2013)
• “Integrity and good judgment must be the cornerstones for all the decisions we make. The first step in meeting this commitment means understanding our values and what we stand for as well as the policies and procedures that are there to underpin these values. The second step is to live and breathe, not only by the letter, but also by the spirit of, these fundamental values and principles.” (Andrew Witty, GlaxoSmithKline CEO in ‘An Introduction to Corporate Ethics and Compliance Integrity’ brochure)
• « Trust and confidence » … presented as the goal of ethical behavior in the health industry in a number of codes of ethics throughout the industry
copyright jean-claude najar
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 29
IVBest Practices
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 30
Some Examples of Best Practices• Codes of conduct/ethics: promoting honest and ethical conduct, including
the ethical handling of actual or apparent conflicts of interests, disclosures, compliance, accountability
• Giving priority to ethics: for example «The rules in the Code of Ethics prevail on all other internal policies issued by corporate bodies while exerting their powers, which policies supplement the Code of Ethics.» (P&R Group Code of Ethics)
• Promote a synergy between subjective corporate ethics (pragmatic) and the objective ethics of the general public/society
• Constant training of employees…. ‘Train the trainers’
• Immediate triggering of internal investigation in case of an allegation of unethical conduct… to exemplify self-regulation
copyright jean-claude najar
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 31
Examples of Codes of Conduct in the Healthcare SectorCode of Conduct for Healthcare Support Workers and Adult Social Care Workers in England (UK Department of Health)
Code de Déontologie des Pharmaciens (2009)
Code of Practice for the Pharmaceutical Industry (Prescription Medicine Code of Practice Authority / Association of the British Pharmaceutical Industry, 2014)
Hospital Corporation of America (HCA) Code of Conduct
Eucomed Guidelines on Interactions with Healthcare Professionals (2008) and Code of Ethical Business Practice: Procedural Framework (2012)
International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) Code of Practice (2012)
US Pharmaceuticals Compliance ant Ethics Code of Conduct
Codes of conduct adopted by all companies active in the healthcare and pharma sectors
copyright jean-claude najar
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 32
• In a letter to the Governor of Florida, the president of Lundbeck wrote that the use of his company's drugs in executions in Florida “contradicts everything Lundbeck is in business to do – provide therapies that improve people's lives.”
• Lundbeck put in place distribution restrictions to prevent its pentobarbital Nembutal from being sold to any prison or corrections department in the US.
Moral Business Choices
copyright jean-claude najar
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 33
GE’s Code of Conduct
Improper PaymentsSupplier RelationshipsInternational Trade ControlsMoney Laundering PreventionPrivacyWorking with GovernmentsComplying with Competition LawsFair Employment PracticesEnvironment, Health & SafetySecurity & Crisis ManagementIntellectual PropertyControllershipConflicts of InterestRegulatory ExcellenceInsider Trading & Stock Tipping
copyright jean-claude najar
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 34
GE’s’The Spirit & The Letter Booklet : Values & Rules
The « Spirit »Ethics
• Doing «the Right Thing»• Values• Beliefs• Learning• Choices
The « Letter »Compliance
• Doing «Things Right»• Rules• Knowledge• Training• Discipline
copyright jean-claude najar
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 35
Any questions?
Thank you for your attention.
[email protected] +33 1 42 68 72 99
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 36
• Biography & Experience of Jean-Claude Najar• Presentation of Curtis Paris Office
ANNEXES
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 37
Mr. Najar is International Counsel based in the Paris and Istanbul offices. His practice is focused on compliance and international arbitration. Mr. Najar has worked on numerous compliance matters, including devising global compliance programs and conducting internal investigations, and has a wealth of experience in cross-business compliance. He represented GE on TI’s Business Principles to Counter Bribery (BPCB) initiative, and also at the OECD’s Anti-Bribery Working Group. He is a member of the ICC’s France Anti-Corruption Commission. He currently participates in an OECD task force drafting an anti-corruption investors’ guide for the MENA region. Mr. Najar teaches Compliance at the Law School of Sciences Po in Paris, and at the healthcare compliance certification programs of INSEAD, and of Sciences Po/Seton Hall Law School. He serves on the anti-corruption Certification Committee of ETHIC Intelligence.
Mr. Najar also has broad experience in international commercial arbitration in a number of sectors, including healthcare, oil & gas, energy, and international contracts. He has been involved in over 100 arbitrations in various capacities, including as arbitrator. Mr. Najar is the founder and a member of the Steering Committee of the Corporate Counsel International Arbitration Group (CCIAG). He is the chair of CPR’s European Executive Board, and a member of various arbitration boards.
His work on the involvement of in-house counsel in arbitration earned him a lifetime Outstanding Achievement Award in 2012. Mr. Najar speaks and publishes extensively on international commercial arbitration, ADR, anti-corruption, compliance, corporate governance, and the role of in-house counsel. Prior to joining Curtis Mr. Najar held several senior in-house counsel positions at GE for close to 24 years, in its Healthcare, Oil & Gas, and Capital businesses, and at Corporate, with the Compliance function always reported to him. He started his career in arbitration in Coudert Frères, a major international law firm in Paris. He is a trained mediator and is admitted to the Paris Bar.Mr. Najar speaks French, English, German, Italian, and Turkish., and has a good command of Spanish.
EDUCATIONUniversité Panthéon Sorbonne (Paris I), DESS, International Commercial Law; Université de Lausanne, Law School, Licence en droit; LSE (London School of Economics & Political Science), LL.M. (Master of Laws).
International CounselCompliance & Arbitration Phone: +33 1 42 68 72 99Email: [email protected]
JEAN-CLAUDE NAJAR
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 38
Compliance Experience
• Close to 24 years with General Electric Co (GE)• VP & General Counsel , GE Medical Systems (now GE Healthcare) for Europe,
the Middle East & Africa (‘EMEA’), Buc, Paris• General Counsel & Director of Government Affairs, GE Oil & Gas worldwide ,
Florence HQ• Senior Counsel & Chief Compliance Officer, GE Capital for the EMEA region,
Paris & London• Always managed the Compliance function: as such dealt with hundreds of
reviews, bottoms-up sessions, issues, internal investigations, drafting of policies and implementing guidelines, various tools, devising reporting procedures, training sessions all over the world… including in Dubai and the UAE…
• Was involved in drafting GE’s code of conduct, The Spirit & the Letter (1993 launch and subsequent editions)
CURTIS, MALLET-PREVOST, COLT & MOSLE LLP 39
Established in 1973, Curtis’ Paris office handles both international and French corporate matters, compliance, and international arbitration. It works closely with the firm’s 14 other offices in Europe, the Americas, the Middle East (Dubai & Muscat) and Central Asia. The Paris office is developing a compliance practice, with program building, training, and internal investigations expertise, in liaison with experts in other Curtis offices, including in the Middle East. It is currently advising a major French multinational and a SWF in compliance. It has also strong corporate, M&A, and tax capabilities, with a niche expertise in management packages and an enviable track record of success in representing international companies in the French market. Curtis Paris is a center of excellence in international commercial and investment arbitration. The team undertakes arbitrations under the ICSID, ICC, UNCITRAL, LCIA, SIAC, DIAC, OHADA, IATA, and other rules. Led by Paris office managing partner Peter Wolrich, the international arbitration team is known for its representation of states and state-owned entities in both investor- state and commercial arbitrations. The Paris office is staffed by a dynamic and highly motivated team that includes French, American, German, and Russian lawyers, admitted to practice in Paris, New York, Frankfurt, and England & Wales. All of Curtis’ Paris-based lawyers are multilingual and have business degrees in addition to their law degrees.
Paris Office Overview
Top Related